Ailomics Therapeutics and Yanyin Tech Announce Strategic Collaboration to Advance Digital and Intelligent Transformation in Biopharmaceutical R&D

Recently,Two innovative companies invested by Qiming Venture Partners have sparked more chemical reactions. Ailomics Therapeutics Co., Ltd (Ailomics), an innovative drug research and development company, has reached a deep collaboration with Shanghai Yanin Technology Co., Ltd (Yanin Technology), a biomedical scientific research collaboration platform.Ailomics Team Starts to Use yanMolecule, the Molecular Biology Module of yanyin Zhiyan Cloud Platform Developed by yanyin Technology. yanyin Zhiyan Cloud Aims to Improve the Efficiency of R&D Personnel and Accelerate the Process of Innovative Drug Development through Technologies Such as Artificial Intelligence.

Ailomics, as an innovative drug research and development enterprise, is committed to the research and development of innovative drugs for immune diseases with significant clinical needs.The core founding team has many years of experience in new drug research and development at international pharmaceutical companies.Ailomics leverages its groundbreaking computational biology platform to conduct in-depth analysis of multi-omics data from patients, identifying new mechanisms and drug targets that drive disease progression, and developing innovative drugs.Ailomics has built an innovative drug R&D pipeline with international competitiveness through independent research and collaboration with top clinical PIs in China.

Dr. Ding Yao, CTO of Ailomics, stated: "By using yanMolecule from Yan Therapeutics, we are able to efficiently and securely manage critical information such as antibody sequences, plasmid constructs, and molecular cloning across multiple projects, enabling internal laboratory information sharing and task collaboration, thereby accelerating the antibody drug development process.""Looking forward to deeper cooperation with Ailomics in the digitalization and intelligentization of pharmaceutical R&D in the future."

Dr. Zeping Chen, founder and CEO of Ailomics, stated: “The digital transformation of pharmaceutical R&D is underway, with relatively cautious progress due to the strict regulatory compliance requirements for R&D experiments and data.However, with the rapid evolution of market business needs, an increasing number of pharmaceutical companies have begun to adopt SaaS cloud platform solutions for the digital management of the R&D process. Thanks to Ailomics for recognizing YanYin Technology. YanYin Zhiyan Cloud, as a digital scientific research collaboration platform specializing in biopharmaceuticals, is committed to working alongside China's outstanding biopharmaceutical enterprises. It aims to help transform the biopharmaceutical R&D process from traditional inefficient paper-based management to a digitally efficient management model, accelerating the digital and intelligent transformation of biopharmaceutical R&D, and contributing to cost reduction and efficiency improvement in enterprise R&D.

Yan Yin Zhi Yan Cloud 1.0

Ailomics provides Academic Edition (Free), Professional Edition, and Enterprise Edition, focusing on offering AI-powered research collaboration platforms and solutions for the biopharmaceutical field.Including molecular biology intelligent platforms, biopharmaceutical large model libraries, electronic laboratory notebooks, and scientific research big data platforms, providing intelligent scientific research services for research institutions and innovative pharmaceutical companies across China.Aiming to help researchers in the biopharmaceutical industry conduct scientific research experiments and data analysis more efficiently, improving the efficiency and quality of research.

Yan Yin Technology hopes to help 100,000 on-campus researchers and scientific research scientists in the biopharmaceutical field through its Academic Version (free) and Professional Version, enabling them to use legitimate molecular biology tools; it also aims to empower 2,000 innovative pharmaceutical companies across China through its Enterprise Version, creating a cost-effective scientific research collaboration platform; Yan Yin Technology hopes to make scientific experiments more efficient.